generic drugs
lborkowski | July 3, 2013The Supreme Court's decisions on marriage equality and the Voting Rights Act got a lot of media attention last week, but several of the Court's other decisions also have implications for public health -- and they came down on the side of employers, real-estate developers, and drug manufacturers.
In a Washington Post op-ed, Georgetown University law professor David Cole warns, "the underlying theme of the Supreme Court’s term was not the recognition of rights, but their dilution." He points to two cases involving employment discrimination:
In a pair of less-noticed decisions released the day…
vlicata | March 10, 2010In the Feb 26 issue of Science, the Chief Patent Counsel for GlaxoSmithKline has written a "Policy Forum" article outlining the reasons that the pharmaceutical industry needs longer and stronger patent protection on its new drugs (to fend off those nasty generics). I was kind of shocked to see such a propaganda piece in Science, but I suppose it is all part of looking at both (all) sides of an issue. Big pharma has been telling us how tough they've got it for years, and the argument that they must charge very high prices to pay for all that R&D is so old that you can probably find it…